Skip to main content
. 2022 Dec 14;13:7748. doi: 10.1038/s41467-022-35378-z

Fig. 5. ARID1A down-regulation sensitizes liver cancer cells to TEAD1 inhibition.

Fig. 5

a Proliferation kinetic of Huh-7 cells (ARID1A wild-type) transfected with control siRNA, ARID1A siRNA, TEAD1 siRNA or both. b Proliferation kinetic of Huh-7 cells transfected with control or ARID1A siRNA and treated with DMSO or verteporfin (1uM). c Dose-response curve of verteporfin in Huh-7 cells transfected with control or ARID1A siRNA. d, e Immunoblot of PARP (d) and apoptosis assay using AnnexinV and propidium iodide (PI) staining (e) of Huh-7 cells transfected with control or ARID1A siRNA 48 h after treatment with DMSO or verteporfin (1 uM). Immunoblot quantification is relative to loading control (actin). f Schematic representation of the CAM assay. g, h Representative pictures (g) and relative volume quantification (h) of tumors explanted from the CAM and derived from Huh-7 cells transfected with control siRNA or ARID1A siRNA and treated with DMSO or verteporfin (1uM). Error bars represent mean (+/−SD) from n ≥ 2 replicated. For all experiments performed, statistical significance was assessed by two-sided multiple t-tests (*P < 0.05, **P < 0.01, ***P < 0.001). f was generated using BioRender.